Magazine Store

February Monthly Edition 2024

5 Best Biotech Companies to Watch 2024

Company Management Description
Prof Mart Saarma,
CSO & Board Member
GeneCode is a multinational R&D company focusing on neurodegenerative diseases. The company specializes in proprietary drug design technologies, creating novel small-molecule drug candidates for diseases like Parkinson’s, Alzheimer’s, ALS, Multiple Sclerosis, and others, aiming for neuroprotective and potentially restorative treatments. GeneCode’s approach is unique because it aims for disease modification and potential cures rather than symptom management.
Antharis Therapeutics
Dr. Raphael Ribeiro-Pinaud,
CEO & Chairman
Antharis Therapeutics is at the forefront of research in monoclonal antibody therapeutics. The company adopts a robust, multi-disciplinary strategy to optimize its research and development workflow, aiming to obtain groundbreaking, therapeutically-efficacious biotherapeutics.
Praedicare Inc
Tawanda Gumbo,
Praedicare's revolutionary SoS approach accelerates drug development. With first-of-its kind integrated multiple wet lab systems, system of mathematical models, suite of AI tools, and clinical trial databases to give outcomes that are emergent properties that reduce timelines 2-3 times, >90% of costs, and maximize phase-by-phase success rates from preclinical phases to NDA/BLA.
Boston Bioprocess
Michael Tai,
Co-founder & CEO
Boston Bioprocess helps biotech companies develop, scale up and optimize fermentation and DSP processes. The company aims to remove knowledge and capacity bottlenecks in the transition from lab to commercial manufacturing.
Veloxity Labs, LLC
Dr. Shane Needham, PhD,
President & CEO
Veloxity Labs is a bioanalytical contract research organization (CRO) specializing in LC-MS/MS bioanalytical services to help pharma and biotech companies develop therapeutics to treat disease.